User:Hippocrates
From Wikimed
(Difference between revisions)
Hippocrates (Talk | contribs) (more) |
Hippocrates (Talk | contribs) (tweek) |
||
| Line 1: | Line 1: | ||
Experiment 1. | Experiment 1. | ||
| - | '''NovoLog Mix 70-30'''. An [[insulin]] preparation, trade name of [[Novo Nordisk]] consisting of 70% insulin aspart protamine suspension and 30% insulin aspart injection of [[rDNA]] origin. It is dispensed in disposable "pens" | + | '''NovoLog Mix 70-30'''. An [[insulin]] preparation, a trade name of [[Novo Nordisk]] consisting of 70% insulin aspart protamine suspension and 30% insulin aspart injection of [[rDNA]] origin. It is dispensed in disposable "pens" which eliminate the need for separate [[hypodermic needle]]s. |
*By prescription only. | *By prescription only. | ||
| - | *[http://novologmix70-30.com/pdf/NovoLogMix7030_PI.pdf manufacturer's prescribing information*.pdf] | + | *[http://novologmix70-30.com/pdf/NovoLogMix7030_PI.pdf manufacturer's prescribing information, *.pdf format]. |
Current revision as of 20:27, 12 July 2006
Experiment 1.
NovoLog Mix 70-30. An insulin preparation, a trade name of Novo Nordisk consisting of 70% insulin aspart protamine suspension and 30% insulin aspart injection of rDNA origin. It is dispensed in disposable "pens" which eliminate the need for separate hypodermic needles.
- By prescription only.
- manufacturer's prescribing information, *.pdf format.
